반응형
| Global Data Intelligence Center | ||
| 구분 | 보고서 (영문) | 업로드 날짜 |
| 제약/바이오/임상시험 | Merck’s MK-0616 Holds Potential to Become the First Oral PCSK9 Inhibitor in the Dyslipidemia Market | 03-09-2023 |
| More Positive Data for Daiichi Sankyo and AstraZeneca’s Blockbuster Drug Enhertu | 03-09-2023 | |
| The State of the Oncology Microbiome Therapeutics Pipeline at a Glance | 03-08-2023 | |
| Eli Lilly Places Price Cap of $35 on Out-of-Pocket Insulin Cost | 03-07-2023 | |
| Positive Results for PD-1 Inhibitors in Front-Line Gastric Cancer, But Who Can Compete With Opdivo? | 03-03-2023 | |
| Toripalimab Can Become the New Standard of Care in Recurrent/Metastatic Nasopharyngeal Carcinoma | 03-03-2023 | |
| Contract Manufacturing: Opportunities and Threats – February 2023 | 03-02-2023 | |
| February Quarterly Contract Manufacturing Mergers, Acquisitions, and Financing – Q1 2023 | 03-02-2023 | |
| Nubeqa Approval to Boost Bayer’s Presence in Prostate Cancer Market in Japan | 03-01-2023 | |
| 질환별 | 30 Years of Failed Trials Put Sepsis on Track to Be the Main Cause of Death by 2050 | 03-09-2023 |
| Angelman Syndrome: Competitive Landscape | 03-06-2023 | |
반응형
'의료기기관련기관 > 국가임상시험지원재단' 카테고리의 다른 글
| <Vendor 기업 주력 사업 조사> (0) | 2023.10.06 |
|---|---|
| [국가임상시험지원재단] 해외 임상시험 정보 데이터(Global Data) 보고서 제공 (0) | 2023.10.06 |
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
| [국가임상시험지원재단] 해외 임상시험 정보데이터 (Global Data) 발간 보고서 제공 (0) | 2023.10.06 |
